MI HR0246

Declares May 5-11, 2024, as Tardive Dyskinesia Awareness Week in Michigan

Tardive dyskinesia (TD) is an involuntary movement disorder characterized by uncontrollable, abnormal repetitive movements affecting the face, torso, limbs, and fingers or toes, associated with prolonged use of dopamine-blocking medications like antipsychotics and antiemetics

Approximately 600,000 people in the United States have TD, with about 65 percent remaining undiagnosed, making awareness-raising important

Encourages healthcare providers to regularly screen patients taking dopamine-blocking medications for TD, as recommended by the American Psychiatric Association, and notes FDA-approved treatments are available

Urges individuals experiencing uncontrollable, abnormal, and repetitive movements to consult their healthcare provider about symptoms